Symptom clusters after chemoradiotherapy in discharged nasopharyngeal carcinoma patients

被引:1
|
作者
Li, Xiang [1 ]
Fu, Gui-Fen [2 ]
Huang, Yu-Ying [1 ]
Jiang, Qing-Yu [1 ]
Huang, Xiao-Yan [1 ]
Zhang, Jin-Tao [1 ]
Qu, Shen-Hong [1 ]
机构
[1] Guangxi Acad Med Sci, Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Otorhinolaryngol, Nanning, Peoples R China
[2] Guangxi Acad Med Sci, Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Nursing, Nanning, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
基金
中国国家自然科学基金;
关键词
nasopharyngeal carcinoma; chemoradiotherapy; symptom clusters; nursing; otorhinolaryngology; PERIODONTAL-DISEASE; RADIATION-THERAPY; CANCER PATIENTS; MUCOSITIS; HEAD;
D O I
10.3389/fonc.2023.920889
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveTo investigate the incidence of complications and types of chemoradiotherepy induces symptom clusters in patients with nasopharyngeal carcinoma (NPC) who were first diagnosed after treatment and discharged from hospital. MethodsAfter their discharge home, 130 NPC patients who had been treated with chemoradiotherapy were asked to complete a modified Chinese version of the Quality of Life Questionnaire-Head and Neck Module developed by the European Organization for the Research and Treatment of Cancer in the Head and Neck. Symptom clusters in patients were identified through exploratory factor analysis. ResultsThe most serious symptoms for discharged NPC patients who had received chemoradiotherapy were dental problems, a sense of obstruction while swallowing, embarrassment in physical contact with family members and friends, difficulty in speaking with others, and embarrassment in public. The six symptom clusters identified through exploratory factor analysis were (1) painful eating, (2) social difficulties, (3) psychological disorders, (4) symptomatic shame, (5) teeth/throat injuries, and (6) sensory abnormalities. The total contribution rate of variance was 65.73%. ConclusionNPC patients who are treated with chemoradiotherapy can experience adverse symptom clusters that continue after discharge. Nurses should evaluate the patients' symptoms before discharge and provide targeted health education services which would reduce the patients' complications and improve the quality of life at home. Besides, medical staff should evaluate the complications in a timely and comprehensive manner and provide individualized health education for the affected patients to help them manage chemoradiotherapy side effects.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Concurrent chemoradiotherapy degrades the quality of life of patients with stage II nasopharyngeal carcinoma as compared to radiotherapy
    Pan, Xin-Bin
    Huang, Shi-Ting
    Chen, Kai-Hua
    Jiang, Yan-Ming
    Ma, Jia-Lin
    Qu, Song
    Li, Ling
    Chen, Long
    Zhu, Xiao-Dong
    ONCOTARGET, 2017, 8 (08) : 14029 - 14038
  • [42] Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy
    Uchinami, Yusuke
    Yasuda, Koichi
    Minatogawa, Hideki
    Dekura, Yasuhiro
    Nishikawa, Noboru
    Kinoshita, Rumiko
    Nishioka, Kentaro
    Katoh, Norio
    Mori, Takashi
    Otsuka, Manami
    Miyamoto, Naoki
    Suzuki, Ryusuke
    Kobashi, Keiji
    Shimizu, Yasushi
    Taguchi, Jun
    Tsushima, Nayuta
    Kano, Satoshi
    Homma, Akihiro
    Aoyama, Hidefumi
    RADIATION ONCOLOGY JOURNAL, 2024, 42 (01): : 74 - 82
  • [43] Toxicity of concurrent chemoradiotherapy with cetuximab for locoregionally advanced nasopharyngeal carcinoma
    Feng, Hui-Xia
    Guo, Su-Ping
    Li, Gui-Rong
    Zhong, Wen-Huan
    Chen, Liu
    Huang, Li-Ru
    Qin, Hui-Ying
    MEDICAL ONCOLOGY, 2014, 31 (09) : 1 - 6
  • [44] Symptom profile of nasopharyngeal cancer patients during radiation therapy
    Huang, HY
    Wilkie, DJ
    Schubert, MM
    Ting, LL
    CANCER PRACTICE, 2000, 8 (06) : 274 - 281
  • [45] The impact of smoking on the clinical outcome of locoregionally advanced nasopharyngeal carcinoma after chemoradiotherapy
    Guo, Shan-Shan
    Huang, Pei-Yu
    Chen, Qiu-Yan
    Liu, Huai
    Tang, Lin-Quan
    Zhang, Lu
    Liu, Li-Ting
    Cao, Ka-Jia
    Guo, Ling
    Mo, Hao-Yuan
    Guo, Xiang
    Hong, Ming-Huang
    Mai, Hai-Qiang
    RADIATION ONCOLOGY, 2014, 9 : 246
  • [46] The impact of smoking on the clinical outcome of locoregionally advanced nasopharyngeal carcinoma after chemoradiotherapy
    Shan-Shan Guo
    Pei-Yu Huang
    Qiu-Yan Chen
    Huai Liu
    Lin-Quan Tang
    Lu Zhang
    Li-Ting Liu
    Ka-Jia Cao
    Ling Guo
    Hao-Yuan Mo
    Xiang Guo
    Ming-Huang Hong
    Hai-Qiang Mai
    Radiation Oncology, 9
  • [47] Temporal lobe microstructural abnormalities in patients with nasopharyngeal carcinoma quantitatively evaluated by high-resolution DWI and DKI after concurrent chemoradiotherapy
    Wu, Gang
    Li, Rui-rui
    Balasubramanian, Priya S.
    Li, Meng-meng
    Yang, Kai
    Huang, Wei-yuan
    Chen, Feng
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 21 : 36 - 43
  • [48] Predicting osteoradionecrosis risk in patients with locoregionally advanced nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: the value of the
    Durankus, Nilufer Kilic
    Somay, Efsun
    Bascil, Sibel
    Senyurek, Sukran
    Ozturk, Duriye
    Selek, Ugur
    Topkan, Erkan
    BIOMOLECULES AND BIOMEDICINE, 2024,
  • [49] Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinoma: a multicenter analysis in Thailand
    Ngamphaiboon, Nuttapong
    Dechaphunkul, Arunee
    Setakornnukul, Jiraporn
    Dechaphunkul, Tanadech
    Jiratrachu, Rungarun
    Suktitipat, Bhoom
    Jiarpinitnun, Chuleeporn
    Pattaranutaporn, Poompis
    Danchaivijitr, Pongwut
    BMC CANCER, 2020, 20 (01)
  • [50] Percutaneous endoscopic gastrostomy can improve survival outcomes in patients with N3 nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy
    Xu, Yun
    Chen, Mengwei
    Guo, Qiaojuan
    Peng, Hewei
    Guo, Lanyan
    Zong, Jingfeng
    Huang, He
    Chen, Bijuan
    Xu, Hanchuan
    Pan, Jianji
    Lin, Shaojun
    ORAL ONCOLOGY, 2021, 121